EFFECT OF ERANDAMULADI DECOCTION ENEMA IN LOW BACK PAIN RADIATING TO LEGS CAUSED BY VATA BASED ON MORBIDITY AND STRENGTH OF MORBIDITY

EFFECT OF ERANDAMULADI NIRUHA VASTI IN VATAJA GRIDHRASI ACCORDING TO DOSHA AND DOSHABALA

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/04/024902

Enrollment

Registered

2020-04-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M543- Sciatica

Interventions

Intervention1: Erandamooladi Nirooha vasti according to dosha and dosha bala: 1 In Mild Dosha & Doshabala person Erandamooladi Nirooha Vasti dose - 700 ml Sahacharadi Sneha Vasti dose -175 ml 2 In

Eligibility

Inclusion criteria

Inclusion criteria: Pre diagnosed case of vataja gridhrasi and they are classified according to dosha bala by an expert Vasti arha mentioned in the classics

Exclusion criteria

Exclusion criteria: Vasti Anarha Diagnosed case of neoplasm bone TB fracture of spine uncontrolled diabetes and uncontrolled hypertension

Design outcomes

Primary

Measure	Time frame
To fix the dose of vasti according to dosha and doshabala To clinically access the effectiveness of erandamuladi niruha vasti dosha bala dose in vataja gridhrasi against standard dvadasha prasrutha doseTimepoint: The assessment will be done on baseline (0th day), and on 6th day after treatment. Follow up will be done on 11th day.	—

Secondary

Measure	Time frame
not applicableTimepoint: not applicable	—

Countries

India

Contacts

Public ContactDr Anandaraman PV

AMRITA SCHOOL OF AYURVEDA

dr.anantharamsharma@gmail.com9495130595

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026